|
ATE291617T1
(de)
*
|
1997-01-24 |
2005-04-15 |
Avi Biopharm Inc |
Verfahren und konjugat zur behandlung von helicobacter pylori-infektionen
|
|
CA2280957A1
(en)
*
|
1997-02-14 |
1998-08-20 |
Leslie Orgel |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
US20020064520A1
(en)
*
|
1999-08-19 |
2002-05-30 |
Yanina Rozenberg |
Targeted artificial gene delivery
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
WO2001013957A2
(en)
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
EP1301525B1
(en)
|
2000-07-06 |
2015-09-02 |
Sarepta Therapeutics, Inc. |
Transforming growth factor beta (tgf-beta) blocking agent-treated stem cell composition and method
|
|
DK1301213T3
(en)
|
2000-07-21 |
2017-03-27 |
Revance Therapeutics Inc |
MULTI-COMPONENT SYSTEMS FOR BIOLOGICAL TRANSPORT
|
|
JP2004523480A
(ja)
*
|
2000-08-22 |
2004-08-05 |
ニュー リバー ファーマシューティカルズ， インコーポレイテッド |
活性作用物質送達系ならびに活性作用物質の保護および投与方法
|
|
CA2428971A1
(en)
*
|
2000-11-14 |
2003-05-01 |
New River Pharmaceuticals Inc. |
Conjugates of a therapeutic agent and a peptide carrier
|
|
EP2316468A1
(en)
*
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
|
ATE512674T1
(de)
|
2003-01-06 |
2011-07-15 |
Angiochem Inc |
Angiopep-1, verwandte verbindungen, und deren verwnedungen
|
|
WO2005072527A2
(en)
|
2004-01-23 |
2005-08-11 |
Avi Biopharma, Inc. |
Antisense oligomers and methods for inducing immune tolerance and immunosuppression
|
|
BRPI0508440A
(pt)
|
2004-03-03 |
2007-07-24 |
Revance Therapeutics Inc |
composições e métodos para diagnóstico tópico e transporte terapêutico
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
AU2005327188C9
(en)
|
2004-07-02 |
2011-09-22 |
Avi Biopharma, Inc. |
Antisense antibacterial method and compound
|
|
WO2006086667A2
(en)
|
2005-02-09 |
2006-08-17 |
Avi Bio Pharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
|
MX2007010113A
(es)
|
2005-02-18 |
2007-12-07 |
Angiochem Inc |
Polipeptidos de aprotinina para transportar un compuesto a traves de la barrera hematoencefalica.
|
|
KR20070110402A
(ko)
|
2005-03-03 |
2007-11-16 |
레반스 테라퓨틱스 |
보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
|
|
ES2362301T3
(es)
|
2005-03-03 |
2011-07-01 |
Revance Therapeutics, Inc. |
Composiciones y procedimientos para aplicaciones tópicas y liberación transdérmica de un oligopéptido.
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
AU2006267051B2
(en)
|
2005-07-13 |
2013-03-07 |
Sarepta Therapeutics, Inc. |
Antisense antibacterial method and compound
|
|
PL2233156T3
(pl)
|
2005-07-15 |
2013-09-30 |
Angiochem Inc |
Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych
|
|
US8501704B2
(en)
|
2005-11-08 |
2013-08-06 |
Sarepta Therapeutics, Inc. |
Immunosuppression compound and treatment method
|
|
EP1935434A1
(en)
*
|
2006-12-19 |
2008-06-25 |
Novosom AG |
Construction and use of transfection enhancer elements
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
US8754056B2
(en)
|
2008-03-20 |
2014-06-17 |
University Of Florida Research Foundation, Inc. |
Enhancing vessel lesion homing and repair potential of stem cells
|
|
EP2143726A1
(en)
*
|
2008-07-11 |
2010-01-13 |
Novosom AG |
Nucleic acid comprising zwitterionic nucleotides
|
|
WO2010043047A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
|
WO2010063122A1
(en)
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
US8592386B2
(en)
*
|
2008-12-17 |
2013-11-26 |
Sarepta Therapeutics, Inc. |
Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
|
|
RU2011146654A
(ru)
|
2009-04-20 |
2013-05-27 |
Ангиокем Инк. |
Способы лечения рака яичников с применением конъюгированного средства
|
|
EP2437772B1
(en)
|
2009-06-05 |
2017-12-06 |
13Therapeutics, Inc. |
Immunoregulatory peptides and methods of use
|
|
WO2011000095A1
(en)
|
2009-07-02 |
2011-01-06 |
Angiochem Inc. |
Multimeric peptide conjugates and uses thereof
|
|
KR101981705B1
(ko)
|
2010-05-28 |
2019-05-24 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체
|
|
WO2012031243A2
(en)
|
2010-09-03 |
2012-03-08 |
Avi Biopharma, Inc. |
dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
|
|
US8580748B2
(en)
|
2011-04-06 |
2013-11-12 |
13Therapeutics, Inc. |
Peptides for the treatment of hearing
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
KR20140097398A
(ko)
|
2011-11-18 |
2014-08-06 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
기능적으로-변형된 올리고뉴클레오티드 및 이의 서브유니트
|
|
US9920085B2
(en)
|
2012-03-20 |
2018-03-20 |
Sarepta Therapeutics, Inc. |
Boronic acid conjugates of oligonucleotide analogues
|
|
GB201210358D0
(en)
*
|
2012-06-12 |
2012-07-25 |
Polytherics Ltd |
Complexes
|
|
CN104781276A
(zh)
|
2012-08-14 |
2015-07-15 |
安吉奥开米公司 |
肽-树枝状聚合物结合物及其用途
|
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
|
US11020417B2
(en)
|
2015-06-04 |
2021-06-01 |
Sarepta Therapeutics, Inc |
Methods and compounds for treatment of lymphocyte-related diseases and conditions
|
|
EP3307326B9
(en)
|
2015-06-15 |
2021-02-24 |
Angiochem Inc. |
Methods for the treatment of leptomeningeal carcinomatosis
|
|
EP3377067A4
(en)
*
|
2015-10-07 |
2019-07-31 |
Cormedix Inc. |
SKIN-PENETRATING FORMULATION OF TAUROLIDINE
|